Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study. - Dorcely B; Sifonte E; Popp C; Divakaran A; Katz K; Musleh S; Jagannathan R; Curran M; Sevick MA; Aleman JO; Goldberg IJ; Bergman M (Endocrine, 2022)